Overview
Urine testing for dysmorphic RBC, haemoglobinuria, and haemosiderinuria is used to evaluate underlying renal and hematological disorders. Dysmorphic RBCs in urine indicate glomerular origin of hematuria, while haemoglobinuria and haemosiderinuria point toward intravascular hemolysis. These tests help differentiate renal causes from urological or systemic causes of blood-related abnormalities in urine.
Dysmorphic RBCs are red blood cells with abnormal size, shape, or membrane distortion, formed when RBCs pass through damaged glomerular basement membranes. Haemoglobinuria refers to free hemoglobin in urine, and haemosiderinuria indicates chronic hemolysis with iron storage pigment excretion. Together, these findings provide valuable diagnostic clues in kidney and blood disorders
Symptoms
Patients with dysmorphic RBCs often present with painless hematuria and proteinuria. Associated symptoms include periorbital puffiness, edema, weight gain, hypertension, oliguria, and dark colored urine. These features are commonly seen in glomerular diseases.
Haemoglobinuria typically presents with deep red to brown discoloration of urine without intact RBCs in urine sediment. It is often more noticeable in early morning samples due to concentrated urine. In some conditions, urine discoloration may be persistent.
Haemosiderinuria presents with brownish urine appearing several days after the onset of hemolysis. Symptoms depend on the underlying hemolytic disorder and may include fatigue, anemia, or signs related to chronic blood destruction.
Causes
Dysmorphic RBCs occur due to glomerular diseases such as glomerulonephritis and IgA nephropathy. Damage to the glomerular filtration barrier causes RBC deformation as they pass into the urine.
Haemoglobinuria is caused by intravascular hemolysis when free hemoglobin exceeds the binding capacity of haptoglobin and renal tubular reabsorption. Causes include hemolytic uremic syndrome, malaria, burns, transfusion reactions, renal inflammation, and certain medications.
Haemosiderinuria results from chronic intravascular hemolysis. Breakdown of hemoglobin leads to haemosiderin deposition in renal tubular cells, which is later excreted in urine. It persists longer than haemoglobinuria and indicates ongoing or past hemolysis.
Risk Factors
Risk factors for dysmorphic RBCs include autoimmune diseases, genetic predisposition, infections, and age-related glomerular conditions. Certain diseases show age and sex predilection, such as lupus nephritis in adolescent girls and post-infectious glomerulonephritis in children.
Haemoglobinuria risk factors include severe infections, burns, crushing injuries, renal disease, blood transfusions, haemolytic anaemias, and exposure to specific drugs such as penicillin, rifampicin, NSAIDs, and intravenous immunoglobulins.
Haemosiderinuria is associated with conditions like paroxysmal nocturnal hemoglobinuria, sickle cell anemia, thalassemia, repeated blood transfusions, renal tubular damage, and disorders causing chronic hemolysis.
Prevention
Prevention focuses on early detection and management of underlying renal and hemolytic conditions. Timely diagnosis of glomerular diseases helps prevent progression to chronic kidney damage.
Avoiding unnecessary drug exposure, monitoring transfusion reactions, and managing infections reduces the risk of haemoglobinuria and haemosiderinuria. Proper hydration and prompt medical attention in cases of dark urine or unexplained hematuria are important.
Regular follow-up, appropriate laboratory monitoring, and correct urine sample collection and handling improve diagnostic accuracy and help prevent complications related to kidney and blood disorders.
